Skip to main content
. 2021 Dec 8;23:300. doi: 10.1186/s13075-021-02688-4

Table 2.

The maximum dosage of glucocorticoids required to achieve rapid remission in AOSD patients

Glucocorticoids (mg/kg/day) Total (n, %) Systemic inflammation type (n, %) Pure type (n, %) Intermediate type (n, %) P value
<0.5 27 (5.5) 6 (3.6) 12 (11.5) 9 (4.1) 0.0097
0.5–1.0 229 (46.7) 59 (34.9) 58 (55.8) 112 (51.6) 0.0006
>1.0 234 (47.6) 104 (61.5) 34 (32.7) 96 (44.2) <0.0001

AOSD Adult-onset Still’s disease